Effects of an estrogen antagonist on behavior and on estrogen retention in neural and peripheral target tissues.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D002369:Castration; D002540:Cerebral Cortex / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000378:metabolism / Q000494:pharmacology*; D004965:Estrogen Antagonists; D005260:Female; D007031:Hypothalamus / Q000187:drug effects; D008636:Mesencephalon / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D013343:Styrenes / Q000494:pharmacology; D014316:Tritium; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D000840:Anisoles; D004965:Estrogen Antagonists; D011759:Pyrrolidines; D011955:Receptors, Drug; D013343:Styrenes; D014316:Tritium; D011374:Progesterone; D004958:Estradiol